Brief: Protagonist No Longer In Compliance With Nasdaq's Audit Committee Composition Requirements

Protagonist Therapeutics

03/07/2023 21:18

July 3 (Reuters) - Protagonist Therapeutics Inc
 PTGX.O :
    * PROTAGONIST- ON JUNE 27,RECEIVED LETTER FROM NASDAQ
CONFIRMING
CO IS NO LONGER IN COMPLIANCE WITH NASDAQ'S AUDIT COMMITTEE
COMPOSITION REQUIREMENTS
    * PROTAGONIST THERAPEUTICS INC - INTENDS TO COMPLY FULLY
WITH
NASDAQ AUDIT COMMITTEE REQUIREMENTS BY OR BEFORE END OF CURE
PERIOD

Source text for Eikon:  ID: 
Further company coverage:  PTGX.O 

 ((Reuters.Briefs@thomsonreuters.com;))